NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that it has launched the HemeScreen® Anemia Panel as part of its suite of ...

(AP) -- Federal health advisers say patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke. A ...

A new drug from Affymax Inc to be used to treat anemia in patients with chronic kidney disease who are on dialysis has won the FDA panel approval. A Food and Drug Administration advisory panel voted ...

WASHINGTON (Reuters) - U.S. health officials will ask an advisory panel whether they should withdraw the approval of Amgen Inc and Johnson & Johnson anemia drugs for cancer chemotherapy patients or ...

Look on the bright side: It could have been worse. An FDA advisory panel voted to keep Amgen and Johnson & Johnson's anemia remedies on the market for cancer patients. So the drugs appear to have ...

Kidney patients who aren't on dialysis should still get their anemia-drug treatments, an FDA advisory panel says. After discussing new safety data on Amgen's high-tech anemia treatment Aranesp, the ...

A U.S. advisory panel called for marketing restrictions on popular anemia drugs sold by Amgen and Johnson & Johnson. Shares of both Amgen and J&J fell on the news. The Food and Drug Administration ...